Red cell distribution width measurement: What role does it have in heart failure?;Determinación del ancho de distribución eritrocitaria. Utilidad en la insuficiencia cardiaca

Revista Espanola de Cardiologia

Volumn 65, Issue 7, 2012, Pages 593-594

  Van Kimmenade, Roland R J ^a   Januzzi, James L ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR DISTRIBUTION; EDITORIAL; ERYTHROCYTE; ERYTHROCYTE FUNCTION AND CHARACTERISTICS; HEART FAILURE; MEASUREMENT;

EID: 84862873910     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.02.018     Document Type: Article

References (13)

1. Bonaque JC, Pascual-Figal DA, Manzano-Fernández S, González-Cánovas C, Vidal A, Muñoz-Esparza C, et al. El ancho de distribución eritrocitaria aporta valor pronóstico adicional en pacientes ambulatorios con insuficiencia cardiaca crónica. Rev Esp Cardiol. 2012;65:606-12.
2. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50:40-7.
3. Van Kimmenade RR, Januzzi Jr JL. Emerging biomarkers in heart failure. Clin Chem. 2012;58:127-38.
4. Januzzi Jr JL, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, et al. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol. 2011;58:1881-9.
5. Jackson CE, Dalzell JR, Bezlyak V, Tsorlalis IK, Myles RC, Spooner R, et al. Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail. 2009;11:1152-4.
6. Van Kimmenade RR, Mohammed AA, Uthamalingam S, Van der Meer P, Felker GM, Januzzi Jr JL. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail. 2010;12:129-36.
7. Anand IS. Pathophysiology of anemia in heart failure. Heart Fail Clin. 2010;6:279-88.
8. Kotecha D, Ngo K, Walters JA, Manzano L, Palazzuoli A, Flather MD. Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials. Am Heart J. 2011;161:822-31.e2.
9. Emans ME, Van der Putten K, Van Rooijen KL, Kraaijenhagen RJ, Swinkels D, Van Solinge WW, et al. Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance. J Card Fail. 2011;17:626-33.
10. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010;16:230-8.
11. Von Haehling S, Anker SD. Cardio-renal anemia syndrome. Contrib Nephrol. 2011;171:266-73.
12. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009;169:515-23.
13. Borne Y, Smith JG, Melander O, Hedblad B, Engstrom G. Red cell distribution width and risk for first hospitalization due to heart failure: a population-based cohort study. Eur J Heart Fail. 2011;13:1355-61.